Work Here?
Industries
Industrial & Manufacturing
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$700K
Headquarters
Chesterfield, Missouri
Founded
2014
Grenova Solutions specializes in reducing plastic waste in laboratories, particularly through its patented products that minimize the use of pipette tips. By implementing these solutions, labs can decrease their plastic waste by up to 90%, resulting in significant cost savings. Grenova differentiates itself by focusing on sustainability and helping clients in the life sciences sector, such as research institutions and pharmaceutical companies, achieve their environmental goals while improving profitability. The company's goal is to transform the lab industry by providing effective, sustainable solutions that enhance operational efficiency.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$700k
Below
Industry Average
Funded Over
2 Rounds
Grenova, a Virginia-based sustainable lab tech firm, announced the appointment of Ted Hull to its board and the completion of a new growth equity round. Hull, with 30+ years in life sciences, will guide Grenova's strategic direction. The funding, led by Peloton Equity and Hamilton Lane's Impact Fund II, will enhance automation, R&D, and team expansion. CEO Katherine Marrs highlighted the investment's role in reducing plastic waste and scaling sustainable lab practices.
In late 2022, Civica announced a nearly $125 million investment to build a 120,000 square-foot sterile manufacturing facility and create more than 180 jobs.
Richmond life sciences laboratory product company Grenova has appointed Richard Pellegrino as its chief research and development officer.
Grenova, a manufacturer of instruments and associated consumables for the life sciences industry, announced the appointment of Katherine Marrs as chief commercial officer.
RICHMOND, Va., April 12, 2023 /PRNewswire/ -- Grenova, Inc., a Virginia-based designer, manufacturer, and distributor of instruments and associated consumables for the life sciences industry, today announced the appointment of Lane Major as President and Chief Executive Officer, and as a member of Grenova's Board of Directors. Most recently, Major served as Vice President and General Manager of Stryker Spine, building and integrating ~$2 billion in investment around medical device and enabling technologies across more than 40 countries.Lane Major, President and Chief Executive Officer at Grenova.Major holds more than 20 years of experience as an entrepreneur, executive, and board member in the medical and life sciences product industry. In 2004, he co-founded K2M, Inc. ("K2M"), a supplier of medical device solutions for complex spine and minimally invasive procedures. Major served in numerous roles during his tenure at K2M, including as Chief Operating Officer and Chief Strategy Officer. During that time, he helped lead the company from $0 to $300 million in revenue, as well as a private equity exit, a 2014 IPO, and K2M's $1.4 billion acquisition by Stryker Corp in 2018
Find jobs on Simplify and start your career today
Industries
Industrial & Manufacturing
Biotechnology
Healthcare
Company Size
11-50
Company Stage
Debt Financing
Total Funding
$700K
Headquarters
Chesterfield, Missouri
Founded
2014
Find jobs on Simplify and start your career today